The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute
- Ministry of Health and Welfare (RS-2023-00215783)
- Ministry of Health and Welfare (HI22C131400)
- Ministry of Science, ICT and Future Planning
This publication has 64 references indexed in Scilit:
- Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host DiseaseStem Cells Translational Medicine, 2018
- IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse modelBiochemical and Biophysical Research Communications, 2017
- Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated ImmunosuppressionStem Cells, 2016
- Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applicationsInternational Journal of Hematology, 2015
- TGF-beta signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantationMolecular Biology Reports, 2014
- Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host DiseaseStem Cells, 2013
- Secondary Treatment of Acute Graft-versus-Host Disease: A Critical ReviewTransplantation and Cellular Therapy, 2012
- Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,Bone, 2003
- Characterization and functionality of cell surface molecules on human mesenchymal stem cellsJournal of Biomedical Science, 2003
- Characterization of cells with osteogenic potential from human marrowBone, 1992